Cargando…
Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis
BACKGROUND: Exposure to proton pump inhibitors (PPIs) has been reported to have a potential role in the development of diabetes. AIM: To determine the association between PPIs and diabetes. METHODS: This meta-analysis is registered on PROSPERO (CRD42022352704). In August 2022, eligible studies were...
Autores principales: | Guo, Yun-Ran, Liu, Xin-Ming, Wang, Gui-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011897/ https://www.ncbi.nlm.nih.gov/pubmed/36926660 http://dx.doi.org/10.4239/wjd.v14.i2.120 |
Ejemplares similares
-
Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
por: Trifan, Anca, et al.
Publicado: (2017) -
Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysis
por: Segna, Daniel, et al.
Publicado: (2021) -
Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis
por: Tantai, Xin-Xing, et al.
Publicado: (2019) -
Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis
por: Boonpheng, Boonphiphop, et al.
Publicado: (2019) -
Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
por: Chen, Baoqing, et al.
Publicado: (2022)